For research use only. Not for therapeutic Use.
IX 207-887 is a novel antiarthritic agent which inhibits the release of interleukin-1 (IL-1).
IX 207-887 is a novel antiarthritic agent which inhibits the release of interleukin-1 (IL-1) from human monocytes and mouse peritoneal macrophages. In all test systems IX 207-887 significantly reduces both biologically active and immunoreactive IL-1 in culture media, whereas the levels of IL-1 in homogenates or lysates are either unaffected or only marginally reduced. IX 207-887 neither affects the adherence of human monocytes nor markedly inhibits IL-1 or IL-2-induced thymocyte proliferation. In the chondrocyte test no IL-1 antagonistic activity of IX 207-887 can be observed[1].
Catalog Number | I046307 |
CAS Number | 98320-39-9 |
Synonyms | (2Z)-2-(8-methoxy-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,8,10,12-hexaen-2-ylidene)acetic acid |
Molecular Formula | C16H12O3S |
Purity | ≥95% |
InChI | InChI=1S/C16H12O3S/c1-19-14-8-10-4-2-3-5-11(10)13(9-15(17)18)12-6-7-20-16(12)14/h2-9H,1H3,(H,17,18)/b13-9- |
InChIKey | XIKRQPKFOKKGGW-LCYFTJDESA-N |
SMILES | COC1=CC2=CC=CC=C2C(=CC(=O)O)C3=C1SC=C3 |
Reference | [1]. Schnyder J, et al. Inhibition of interleukin-1 release by IX 207-887. Agents Actions. 1990 Jun;30(3-4):350-62. |